Phase separation of RXRγ drives tumor chemoresistance and represents a therapeutic target for small-cell lung cancer

Journal:

Proceedings of the National Academy of Sciences of the United States of America

Published:

2025-05-20

DOI:

10.1073/pnas.2421199122

Affiliations:

8

Authors:

16

Go to article

Institutions	Authors	Share
Sun Yat-sen University (SYSU), China	8.000000	0.50
State Key Laboratory of Oncology in South China, SYSUCC, China	2.000000	0.13
Guangdong Academy of Medical Sciences (Guangdong Provincial People’s Hospital), China	1.000000	0.06
Foshan First People's Hospital, China	1.000000	0.06
National‐Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, SYSU, China	1.000000	0.06
UC Davis Comprehensive Cancer Center, United States of America (USA)	1.000000	0.06
The Third Affiliated Hospital, SYSU, China	1.000000	0.06
Jinan University (JNU), China	1.000000	0.06

Interested in Oncology and Carcinogenesis?